Editas Medicine Inc (EDIT)

Editas Medicine (EDIT) Stock Price & Analysis


EDIT Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$6.33 - $14.23
Previous Close$7.95
Average Volume (3M)1.41M
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$431.97M
Total Debt (Recent Filing)$37.19M
Price to Earnings (P/E)-2.7
Nov 08, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.97
Shares Outstanding81,632,619
10 Day Avg. Volume1,377,121
30 Day Avg. Volume1,408,516
Standard Deviation0.26
Financial Highlights & Ratios
Price to Book (P/B)1.64
Price to Sales (P/S)224.79
Price to Cash Flow (P/CF)-4.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Price Target Upside84.95% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Editas Medicine Inc’s price range in the past 12 months?
Editas Medicine Inc lowest stock price was $6.33 and its highest was $14.23 in the past 12 months.
    What is Editas Medicine Inc’s market cap?
    Currently, no data Available
    When is Editas Medicine Inc’s upcoming earnings report date?
    Editas Medicine Inc’s upcoming earnings report date is Nov 08, 2023 which is in 48 days.
      How were Editas Medicine Inc’s earnings last quarter?
      Editas Medicine Inc released its earnings results on Aug 02, 2023. The company reported -$0.56 earnings per share for the quarter, beating the consensus estimate of -$0.767 by $0.207.
        Is Editas Medicine Inc overvalued?
        According to Wall Street analysts Editas Medicine Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Editas Medicine Inc pay dividends?
          Editas Medicine Inc does not currently pay dividends.
          What is Editas Medicine Inc’s EPS estimate?
          Editas Medicine Inc’s EPS estimate is -$0.58.
            How many shares outstanding does Editas Medicine Inc have?
            Editas Medicine Inc has 81,632,620 shares outstanding.
              What happened to Editas Medicine Inc’s price movement after its last earnings report?
              Editas Medicine Inc reported an EPS of -$0.56 in its last earnings report, beating expectations of -$0.767. Following the earnings report the stock price went up 5.665%.
                Which hedge fund is a major shareholder of Editas Medicine Inc?
                Among the largest hedge funds holding Editas Medicine Inc’s share is Woodline Partners LP. It holds Editas Medicine Inc’s shares valued at 23M.


                  Editas Medicine Stock Smart Score

                  The Editas Medicine stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Editas Medicine Inc

                  Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.


                  Top 5 ETFs holding EDIT

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Vanguard Health Care ETF
                  iShares U.S. Tech Breakthrough Multisector ETF
                  FlexShares Morningstar US Market Factor Tilt Index Fund
                  Vanguard Russell 3000 ETF
                  Up to five ETFs with an Outperform Smart Score that hold EDIT. The ETFs are listed according to market value of EDIT within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Crispr Therapeutics AG
                  Intellia Therapeutics
                  Beam Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis